craft-sa-dev Home  

PMC:1283364 / 1067-1418 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T315 8-9 . denotes .
T316 9-169 sentence denotes We show that doxycycline administration inhibits transgenic APP expression by greater than 95% and reduces Aβ production to levels found in nontransgenic mice.
T317 10-12 PRP denotes We
T318 13-17 VBP denotes show
T319 18-22 IN denotes that
T321 23-34 NN denotes doxycycline
T322 35-49 NN denotes administration
T320 50-58 VBZ denotes inhibits
T323 59-69 JJ denotes transgenic
T325 70-73 NN denotes APP
T324 74-84 NN denotes expression
T326 85-87 IN denotes by
T327 88-95 JJR denotes greater
T329 96-100 IN denotes than
T328 101-103 CD denotes 95
T330 103-104 NN denotes %
T331 105-108 CC denotes and
T332 109-116 VBZ denotes reduces
T333 117-119 NN denotes Aβ
T334 120-130 NN denotes production
T335 131-133 IN denotes to
T336 134-140 NNS denotes levels
T337 141-146 VBN denotes found
T338 147-149 IN denotes in
T339 150-163 JJ denotes nontransgenic
T340 164-168 NNS denotes mice
T341 168-169 . denotes .
T342 169-275 sentence denotes Suppression of transgenic Aβ synthesis in this model abruptly halts the progression of amyloid pathology.
T343 170-181 NN denotes Suppression
T345 182-184 IN denotes of
T346 185-195 JJ denotes transgenic
T348 196-198 NN denotes Aβ
T347 199-208 NN denotes synthesis
T349 209-211 IN denotes in
T350 212-216 DT denotes this
T351 217-222 NN denotes model
T352 223-231 RB denotes abruptly
T344 232-237 VBZ denotes halts
T353 238-241 DT denotes the
T354 242-253 NN denotes progression
T355 254-256 IN denotes of
T356 257-264 NN denotes amyloid
T357 265-274 NN denotes pathology
T358 274-275 . denotes .
T360 276-283 RB denotes However
T362 283-285 , denotes ,
T363 285-294 NN denotes formation
T364 295-298 CC denotes and
T365 299-313 NN denotes disaggregation
T366 314-316 IN denotes of
T367 317-324 NN denotes amyloid
T368 325-333 NNS denotes deposits
T361 334-340 VBP denotes appear
T369 341-343 TO denotes to
T370 344-346 VB denotes be
T371 347-349 IN denotes in
R162 T317 T318 nsubj We,show
R163 T319 T320 mark that,inhibits
R164 T320 T318 ccomp inhibits,show
R165 T321 T322 compound doxycycline,administration
R166 T322 T320 nsubj administration,inhibits
R167 T323 T324 amod transgenic,expression
R168 T324 T320 dobj expression,inhibits
R169 T325 T324 compound APP,expression
R170 T326 T320 prep by,inhibits
R171 T327 T328 amod greater,95
R172 T328 T330 nummod 95,%
R173 T329 T328 quantmod than,95
R174 T330 T326 pobj %,by
R175 T331 T320 cc and,inhibits
R176 T332 T320 conj reduces,inhibits
R177 T333 T334 compound Aβ,production
R178 T334 T332 dobj production,reduces
R179 T335 T332 prep to,reduces
R180 T336 T335 pobj levels,to
R181 T337 T336 acl found,levels
R182 T338 T337 prep in,found
R183 T339 T340 amod nontransgenic,mice
R184 T340 T338 pobj mice,in
R185 T341 T318 punct .,show
R186 T343 T344 nsubj Suppression,halts
R187 T345 T343 prep of,Suppression
R188 T346 T347 amod transgenic,synthesis
R189 T347 T345 pobj synthesis,of
R190 T348 T347 compound Aβ,synthesis
R191 T349 T343 prep in,Suppression
R192 T350 T351 det this,model
R193 T351 T349 pobj model,in
R194 T352 T344 advmod abruptly,halts
R195 T353 T354 det the,progression
R196 T354 T344 dobj progression,halts
R197 T355 T354 prep of,progression
R198 T356 T357 compound amyloid,pathology
R199 T357 T355 pobj pathology,of
R200 T358 T344 punct .,halts
R201 T360 T361 advmod However,appear
R202 T362 T361 punct ", ",appear
R203 T363 T361 nsubj formation,appear
R204 T364 T363 cc and,formation
R205 T365 T363 conj disaggregation,formation
R206 T366 T363 prep of,formation
R207 T367 T368 compound amyloid,deposits
R208 T368 T366 pobj deposits,of
R209 T369 T370 aux to,be
R210 T370 T361 xcomp be,appear
R211 T371 T370 prep in,be